#1 Clinical Trials Search in Europe

Remifentanil

This article examines the use of remifentanil, a potent short-acting opioid, in various clinical trials. Remifentanil is primarily used for anesthesia and pain management during medical procedures. The trials investigate its effectiveness, optimal dosing, and comparisons to other medications across different patient groups and medical contexts. Understanding these studies can provide insights into how remifentanil is being utilized and evaluated in clinical settings.

Table of Contents

What is Remifentanil?

Remifentanil is a powerful pain medication that belongs to a class of drugs called opioids. It is primarily used during surgical procedures to provide pain relief and sedation. Remifentanil is known by various brand names, including Ultiva[1] and Remiva[2]. This medication is administered intravenously (through a vein) and is known for its rapid onset and short duration of action[3].

Uses of Remifentanil

Remifentanil is primarily used in the following medical situations:

  • General anesthesia: It is used as part of general anesthesia during various surgical procedures, including head and neck, thoracic, urological, orthopedic, and plastic surgeries[1].
  • Conscious sedation: Remifentanil can be used for conscious sedation during procedures like endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA), which is used to diagnose and stage lung cancer[4].
  • Pain management during intubation: It is used to manage pain and reduce physiological responses during tracheal intubation (inserting a breathing tube)[5].
  • Post-operative pain relief: Remifentanil can be used for managing pain after surgery, such as in patients who have undergone thoracotomy (chest surgery)[6].

How Remifentanil Works

Remifentanil works by binding to specific receptors in the brain and spinal cord called opioid receptors. This action helps to block pain signals and reduce the perception of pain. Additionally, it can produce sedation and suppress certain reflexes, which is beneficial during surgical procedures[3].

One unique feature of remifentanil is its rapid onset and offset of action. This means that its effects start quickly after administration and also wear off quickly when the infusion is stopped. This characteristic allows for precise control of pain relief during procedures and quick recovery afterward[7].

Administration and Dosage

Remifentanil is typically administered through a method called Target Controlled Infusion (TCI). This involves using a specialized infusion pump that calculates and adjusts the dose based on factors such as the patient’s age, weight, and desired effect[2].

The dosage of remifentanil can vary depending on the specific procedure and the patient’s individual needs. For example:

  • For general anesthesia in children, a starting dose of 0.25 μg/kg/min (micrograms per kilogram per minute) may be used, with adjustments made as needed[1].
  • For conscious sedation during EBUS-TBNA procedures, a target concentration between 3 and 6 ng/ml (nanograms per milliliter) in the blood may be used[4].
  • For preventing pain during propofol injection in elderly patients, the optimal dose may be different from that used in younger adults[8].

Effectiveness

Remifentanil has been shown to be effective in various clinical settings:

  • It can effectively suppress pain responses during surgical procedures, such as laryngoscopy (examining the voice box) and intubation[3].
  • When used in combination with other anesthetics, it can provide stable anesthesia and good operating conditions for surgeons[1].
  • In post-operative pain management, remifentanil can be effective when used in combination with other pain medications[6].

Side Effects and Safety

Like all medications, remifentanil can cause side effects. Some potential side effects include:

  • Respiratory depression: This is a slowing or stopping of breathing, which is why patients are closely monitored during its use[4].
  • Cardiovascular effects: It may cause changes in heart rate and blood pressure[5].
  • Nausea and vomiting: These are common side effects of opioid medications[9].
  • Muscle rigidity: In some cases, it may cause stiffness in the chest muscles[4].

Due to these potential side effects, remifentanil is only administered by trained healthcare professionals in settings where patients can be closely monitored.

Comparison with Other Medications

Remifentanil is often compared to or used in combination with other medications:

  • It may be used as an alternative to or in combination with other opioids like fentanyl or sufentanil[10].
  • In some procedures, it may be compared to or used alongside non-opioid medications like dexmedetomidine for sedation and pain control[9].
  • Remifentanil is often used in combination with propofol, another anesthetic medication, for inducing and maintaining anesthesia[8].

Special Considerations

There are some special considerations when using remifentanil:

  • Age: The dosing may need to be adjusted for elderly patients, as they may be more sensitive to its effects[8].
  • Cardiopulmonary bypass: The pharmacokinetics (how the body processes the drug) of remifentanil may change during heart surgeries involving cardiopulmonary bypass[2].
  • Pediatric use: Remifentanil can be used in children, but dosing and monitoring may differ from adults[1].
  • Generic vs. branded: There may be differences between branded and generic versions of remifentanil, which healthcare providers need to be aware of[5].
Aspect Details
Primary Uses Anesthesia, pain management, sedation during medical procedures
Key Characteristics Ultra-short-acting, rapid metabolism, predictable pharmacokinetics
Patient Groups Studied Pediatric, elderly, critically ill, adults undergoing specific procedures
Procedures Investigated Surgery, colonoscopy, ESWL, tracheal intubation, cardiopulmonary bypass
Outcome Measures Pain scores, hemodynamic stability, coughing incidence, recovery time, BIS
Comparisons Other opioids, anesthetic combinations, branded vs. unbranded versions
Administration Methods Continuous infusion, target-controlled infusion, bolus doses
Potential Benefits Faster recovery, reduced side effects, conscious sedation capability

FAQ

  • What is remifentanil used for in clinical trials? Remifentanil is primarily used in clinical trials for anesthesia and pain management during various medical procedures, including surgery, colonoscopy, and extracorporeal shock wave lithotripsy (ESWL). It is being studied for its effectiveness in providing sedation, preventing coughing during anesthesia emergence, and managing pain in critically ill patients.
  • How does remifentanil compare to other pain medications? Some trials compare remifentanil to other medications or combinations. For example, one study compared propofol-ketamine vs remifentanil-ketamine for sedation in pediatric patients undergoing colonoscopy. Another trial compared branded and unbranded remifentanil molecules to assess if there were differences in their effectiveness.
  • What are some potential benefits of using remifentanil? Remifentanil is an ultra-short-acting opioid that is quickly metabolized, allowing for predictable pharmacokinetics. This makes it suitable for continuous intravenous infusion and conscious sedation. Its rapid elimination can lead to faster recovery times, potentially reducing side effects and time spent in recovery rooms, especially in day surgery settings.
  • Are there any specific patient groups being studied with remifentanil? Yes, various patient groups are being studied. These include pediatric patients undergoing procedures like colonoscopy, elderly patients receiving anesthesia, critically ill patients in intensive care units (ICUs), and adults undergoing specific procedures such as extracorporeal shock wave lithotripsy (ESWL) or tracheal intubation.
  • What are some of the outcomes being measured in remifentanil trials? Trials are measuring various outcomes, including pain scores, hemodynamic stability (blood pressure and heart rate), incidence of coughing during anesthesia emergence, time to recovery from anesthesia, patient satisfaction, and side effects. Some studies also look at specific measures like the Bispectral Index (BIS) for monitoring analgesia in sedated patients.

Ongoing Clinical Trials on Remifentanil

  • Study on the Effectiveness of Sphenopalatine Ganglion Block vs. Scalp Block in Patients Undergoing Craniotomy for Supratentorial Mass Using Levobupivacaine and Drug Combination

    Recruiting

    1 1 1
    Investigated drugs:
    Belgium

  • Study on Propofol and Remifentanil for Patients with Heart Disease Undergoing Cardiac Anesthesia with Cardiopulmonary Bypass

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria

  • Study on Sedation During Transcatheter Aortic Valve Replacement in Patients with Aortic Stenosis Using Remifentanil, Dexmedetomidine, and Propofol

    Recruiting

    1 1 1 1
    Investigated drugs:
    Italy

  • Study on Remifentanil and Sodium Chloride for Safe Intubation in Stable Newborns

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium

  • Study on the Effects of Esketamine and Remifentanil on Breathing in Healthy Volunteers

    Not recruiting

    1 1 1
    Investigated drugs:
    The Netherlands

  • Study on Spinal vs. General Anaesthesia with Ropivacaine Hydrochloride for Osteoarthritis Patients Undergoing Hip and Knee Replacement

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

  • Study on the Impact of Sufentanil Citrate and Remifentanil on Heart Rate During Rapid Sequence Intubation in Patients Over 55 with High Anesthesia Risk

    Not recruiting

    1 1 1
    Investigated drugs:
    France

Glossary

  • Remifentanil: An ultra-short-acting opioid medication used for anesthesia and pain management. It is quickly metabolized by blood and tissue enzymes, allowing for rapid onset and offset of effects.
  • Target Controlled Infusion (TCI): A method of administering intravenous anesthesia where a computer model is used to calculate and adjust drug infusion rates to achieve and maintain a specific target drug concentration in the body.
  • Extracorporeal Shock Wave Lithotripsy (ESWL): A non-invasive procedure used to break up kidney stones and upper urinary tract stones using shock waves.
  • Bispectral Index (BIS): A measure of the depth of anesthesia, calculated from electroencephalogram (EEG) data. It is used to monitor the level of consciousness during general anesthesia.
  • Pharmacokinetics: The study of how a drug moves through the body, including its absorption, distribution, metabolism, and excretion.
  • Cardiopulmonary Bypass: A technique that temporarily takes over the function of the heart and lungs during surgery, maintaining the circulation of blood and the oxygen content of the body.
  • Tracheal Intubation: The placement of a flexible plastic tube into the trachea (windpipe) to maintain an open airway or to serve as a conduit through which to administer certain drugs.
  • Propofol: An intravenous anesthetic agent used for the induction and maintenance of general anesthesia and sedation in clinical procedures.

References

  1. https://clinicaltrials.gov/study/NCT01998165
  2. https://clinicaltrials.gov/study/NCT02566733
  3. https://clinicaltrials.gov/study/NCT01912118
  4. https://clinicaltrials.gov/study/NCT06033729
  5. https://clinicaltrials.gov/study/NCT02048293
  6. https://clinicaltrials.gov/study/NCT01830296
  7. https://clinicaltrials.gov/study/NCT02206022
  8. https://clinicaltrials.gov/study/NCT03330782
  9. https://clinicaltrials.gov/study/NCT05772832
  10. https://clinicaltrials.eu/trial/study-on-the-impact-of-sufentanil-citrate-and-remifentanil-on-heart-rate-during-rapid-sequence-intubation-in-patients-over-55-with-high-anesthesia-risk/